Combing resting state functional magnetic resonance imaging with chemogenetic modulation to characterize connectivity of the Salience Network
将静息态功能磁共振成像与化学遗传学调制相结合来表征显着网络的连接性
基本信息
- 批准号:10464079
- 负责人:
- 金额:$ 4.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-05 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgonistAmygdaloid structureAnatomyAnteriorAnxiety DisordersAttentionAwardAxonBindingBiologicalBrainBrain DiseasesBrain regionCellsClozapineCognitiveComb animal structureCommunicationComplexCuesData AnalysesDecision MakingDetectionDiagnosisDiseaseDoctor of PhilosophyDoseDrug ReceptorsEmotionalEtiologyExperimental DesignsFacultyFunctional Magnetic Resonance ImagingFutureG-Protein-Coupled ReceptorsGoalsHumanInjectionsLearningLigand BindingLigandsLinkMRI ScansMajor Depressive DisorderManuscriptsMeasuresMediatingMental disordersNeuronsOralOxidesPenetrancePharmaceutical PreparationsPopulationPositioning AttributeResearchResourcesRestRodentScanningSchizophreniaSensorySignal TransductionStatistical Data InterpretationStimulusTechniquesTechnologyThalamic structureTimeTrainingUniversitiesVentral StriatumVentral Tegmental AreaViralViral VectorWorkWritingautism spectrum disorderbaseblood oxygen level dependentcareercingulate cortexcomputer programdesigndesigner receptors exclusively activated by designer drugsexperimental studyhemodynamicsin vivoinsightnetwork dysfunctionneuroimagingneuropsychiatric disordernonhuman primatenovelnovel strategiesreceptorrelating to nervous systemskillsspecific biomarkers
项目摘要
Project Summary
We are constantly confronted with numerous stimuli that compete for limited neural
resources. A salient cue is one that is important and noticeable. The Salience Network (SN), a
set of brain regions that are consistently co-activated across different conditions and at rest, is
involved in the detection of attention-commanding external and internal stimuli for properly
allocating cognitive resources. Importantly, abnormal activity in the SN is implicated in various
psychiatric disorders, including schizophrenia, anxiety disorders and major depressive
disorders. The main nodes of the SN are the Anterior Cingulate Cortex (ACC), the Anterior
Insular Cortex (AIC), the ventral striatum, ventral tegmental area, dorsomedial thalamus and the
amygdala. These regions are anatomically and functionally connected. The experiments
described in this proposal will delineate how the anatomical and functional connectivity these
brain regions allow them to operate as a network.
This proposal combines chemogenetic circuit-based manipulations with resting state
functional magnetic resonance imaging (rs-fMRI), which measures the changes in
hemodynamic signals in the brain. The goal of Specific Aim 1) Characterize the effects of
chemogenetic ligands on resting state functional connectivity prior to viral expression of
designer receptors exclusively activated by designer drugs (DREADDs). Because chemogenetic
ligands can bind to non-DREADD receptors, this type of characterization is essential before
proceeding with DREADD manipulations. In Specific Aim 2, I will combine DREADDs activation
with rs-fMRI to target the ACC to probe the relationship between rs-functional connectivity and
direct anatomical connections of the Salience Network.
Understanding the relationship between the anatomy and the functional activity of the
Salience Network will have implications for neuroimaging studies that have identified specific
abnormalities in the Salience Network. Furthermore, these studies could detail generalizable
rules for the biological relationship between anatomical and functional connectivity across the
brain, which will have implications for understanding healthy and disordered brain functioning
with the potential for developing novel treatments.
This award will allow me to gain important skills in my PhD research. I will learn complex
techniques, learn to design experiments, perform statistical analyses, write scientific
manuscripts, and practice oral presentations of these studies. All of these will help prepare me
for an academic faculty position.
项目摘要
我们不断地面临着众多的刺激,竞争有限的神经
资源一个突出的线索是一个重要的和明显的。显著性网络(SN),a
一组在不同条件下和休息时持续共同激活的大脑区域,
参与注意力控制的外部和内部刺激的检测,
分配认知资源。重要的是,SN中的异常活动涉及多种疾病。
精神疾病,包括精神分裂症、焦虑症和重度抑郁症
紊乱SN的主要节点是前扣带皮层(ACC)、前扣带皮层(ACC)和前扣带皮层(ACC)。
岛叶皮层(AIC)、腹侧纹状体、腹侧被盖区、背内侧丘脑和
杏仁核这些区域在解剖学上和功能上是相互连接的。实验
在这个建议中描述的将描绘如何解剖和功能连接,这些
大脑区域使它们能够像网络一样运作。
该建议将基于化学发生回路的操作与静息状态相结合
功能性磁共振成像(rs-fMRI),它测量了
大脑中的血液动力学信号。具体目标的目标1)描述
在病毒表达之前,化学遗传配体对静息状态功能连接的影响
设计师受体专门由设计师药物激活(DREADDs)。因为化学基因
配体可以结合到非DREADD受体,这种类型的表征是必不可少的,
进行DREADD操作。在Aim Specific 2中,我将结合联合收割机DREADD激活
用rs-fMRI靶向ACC,以探讨rs功能连接与
显著性网络的直接解剖学连接。
了解解剖和功能活动之间的关系,
显著性网络将对神经影像学研究产生影响,这些研究已经确定了特定的
显著性网络中的异常此外,这些研究可以详细概括
跨组织的解剖和功能连接之间的生物学关系的规则
这将对理解健康和紊乱的大脑功能产生影响
具有开发新疗法的潜力。
这个奖项将使我在我的博士研究中获得重要的技能。我将学习复杂
技术,学习设计实验,进行统计分析,写科学
手稿,并练习口头介绍这些研究。所有这些都能帮助我
一个学术教师的职位
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adriana kelly-Ann Cushnie其他文献
Adriana kelly-Ann Cushnie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adriana kelly-Ann Cushnie', 18)}}的其他基金
Combing resting state functional magnetic resonance imaging with chemogenetic modulation to characterize connectivity of the Salience Network
将静息态功能磁共振成像与化学遗传学调制相结合来表征显着网络的连接性
- 批准号:
10584561 - 财政年份:2022
- 资助金额:
$ 4.37万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 4.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 4.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)